Results 101 to 110 of about 51,875 (217)

In vitro and in vivo development of rifampin resistance with Staphylococcus aureus clinical isolates

, 2022
Purpose: Rifampin is an older antibiotic used to treat several types of bacterial infections including tuberculosis. It is highly active against Staphylococcus aureus and effective against infections with this pathogen.
Madunezim, Quentin
core  

Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii

, 2001
The increased incidence of nosocomial infections by multidrug-resistant Acinetobacter spp creates demand on the application of some combinations of older antimicrobials on that species.
Xirouchaki, E, Giamarellou, H, Giamarellos-Bourboulis, EJ   +2 more
core  

Radiological and Stereological Evaluation of the Effect of Rifampin on Bone Healing in Critical-Size Defects

, 2016
Objectives:This study aimed to investigate the effect of rifampin with autogenous bone on bone regeneration in critical-size defects in the calvaria of rats.Materials and Methods:In total, 40 rats were divided into 4 groups and a 5-mm diameter of ...
TÜRER, AKİF, Celik, Hakan H., ÖNGER, MEHMET EMİN, BALLI, UMUT, DURMUŞLAR, MUSTAFA CENK, Onger, Mehmet E.   +5 more
core   +1 more source

Rapid Determination of Rifampin Resistance in Clinical Isolates of Mycobacterium Tuberculosis by Real-Time Pcr

, 2005
Real-time PCR was used to determine rifampin resistance in clinical isolates of Mycobacterium tuberculosis. Ninety-six rifampin-resistant isolates and 23 rifampin-susceptible isolates were included in the study.
Alp, Alpaslan, Kocagöz, Tanıl, Sarıbaş, Zeynep, Kocagoz, T, Saribas, Z   +4 more
core   +1 more source

Combinations of Antibiotics Effective against Extensively- and Pandrug-Resistant Acinetobacter baumannii Patient Isolates

Microorganisms
Infections due to drug-resistant Acinetobacter baumannii strains are increasing and cause significant morbidity and mortality, especially in hospitalized and critically ill patients. A.
Justin Halim, Rachel A. Carr, Rebecca Fliorent, Keertana Jonnalagadda, Maftuna Kurbonnazarova, Muskanjot Kaur, Ian Millstein, Valerie J. Carabetta   +7 more
doaj   +1 more source

Characterization of Mutations in the rpoB Gene Associated with Rifampin Resistance in Rhodococcus equi Isolated from Foals

, 2001
International audienceTreatment with a combination of erythromycin and rifampin has considerably improved survival rates of foals and immunocompromised patients suffering from severe pneumonia caused by Rhodococcus equi .
Leclercq, Roland, Taouji, Said, Pronost, Stéphane, Maillard, Karine, Fines, Marguerite   +4 more
core   +1 more source

Etymologia: Rifampin

Emerging Infectious Diseases, 2018
Ronnie Henry
doaj   +1 more source

Molecular basis of rifampin resistance in Mycobacterium leprae.

Rifampin is currently the most potent drug used in leprosy control programs. We show that the rifampin resistance which emerged in nine patients with lepromatous leprosy, who had received rifampin monotherapy, stemmed from mutations in the rpoB gene ...
Honore, N, Cole, S T
core   +1 more source

Rifampin-associated tubulointersititial nephritis and Fanconi syndrome presenting as hypokalemic paralysis

, 2013
Background Rifampin is one of the most important drugs in first-line therapies for tuberculosis. The renal toxicity of rifampin has been reported sporadically and acute tubulointerstitial nephritis (ATIN) is a frequent histological finding.
Kim Eun Oh, Hwang Hyeon Seok, Suh Kwang Sun, Kim Suk Young, Yang Chul Woo, Lee Sang Ju, Min Hong Ki, Chang Yoon Kyung   +7 more
core   +1 more source

Susceptibility to penicillin and rifampin by year-Andean region.

, 2012
Susceptibility to penicillin and rifampin by year-Andean region.
Ana Belén Ibarz-Pavón (138381), Ana Paula Lemos (138384), Mabel Regueira (138389), Maria Cecilia Gorla (138386), Jean-Marc Gabastou (138393), SIREVA Working Group II (138391)   +5 more
core   +1 more source